Clinical trial
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in…
NCT00006747 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00006747 |
|---|---|
| Title | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma |
| Official title | Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease, Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | carmustine, melphalan, etoposide, cytarabine, tacrolimus, methotrexate, sargramostim, transplant |
| Enrollment | 4 |
| Start date | Nov 1, 2000 |
| Primary completion | Feb 1, 2003 |
| Completion | Feb 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 19, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: